FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W156085488> ?p ?o ?g. }

• W156085488 endingPage "24" @default.
• W156085488 startingPage "24" @default.
• W156085488 abstract "This review is intended to provide an updated role of molecular genetics and various targeted therapies that have been developed to treat advanced stages of melanoma. Because of the declining success in melanoma therapy, the curative treatment for advanced stage melanoma has been a challenge for clinicians. Several mutations such as N-RAS, p53, BRAF including mutant-BRAF that lead to activation of kinase pathway, are implicated in the development of malignant melanoma. However, the current literature depicts that the prognostic role of BRAF mutation in disease progression is still controversial. While its higher level in advanced stage disease is associated with decreased overall survival (OS), some studies show that it failed to confer as an independent prognostic predictor of the disease. This has also led researchers to accomplish newer therapeutic strategies that lead to improved disease-response and grant survival benefits. Vemurafenib, a BRAF inhibitor agent, is one of the few available targeted therapies that is FDA approved and provides promising results in metastatic disease. However, its resistance at an early stage is of great concern. Recent implementation of combinational therapies including targeted therapy, immunotherapy, and biological agents has appealed many researchers to define the adjunctive role of available therapies and their limitations in advanced stage and metastatic melanoma. This commends the need for future multi-institutional studies to confirm the clinical validity of different therapeutic strategies on a large scale population." @default.
• W156085488 created "2016-06-24" @default.
• W156085488 creator A5001286058 @default.
• W156085488 creator A5028598126 @default.
• W156085488 creator A5039457224 @default.
• W156085488 creator A5071277883 @default.
• W156085488 date "2015-02-01" @default.
• W156085488 modified "2023-09-29" @default.
• W156085488 title "Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research." @default.
• W156085488 cites W1828940258 @default.
• W156085488 cites W1982393730 @default.
• W156085488 cites W1983793008 @default.
• W156085488 cites W1985821753 @default.
• W156085488 cites W1985928174 @default.
• W156085488 cites W1996080211 @default.
• W156085488 cites W1996429288 @default.
• W156085488 cites W2009713492 @default.
• W156085488 cites W2023046293 @default.
• W156085488 cites W2025507668 @default.
• W156085488 cites W2031134972 @default.
• W156085488 cites W2034048944 @default.
• W156085488 cites W2043103956 @default.
• W156085488 cites W2051588742 @default.
• W156085488 cites W2056918351 @default.
• W156085488 cites W2074089133 @default.
• W156085488 cites W2075104267 @default.
• W156085488 cites W2076071381 @default.
• W156085488 cites W2102646127 @default.
• W156085488 cites W2124662474 @default.
• W156085488 cites W2128156393 @default.
• W156085488 cites W2128542677 @default.
• W156085488 cites W2129245282 @default.
• W156085488 cites W2133717967 @default.
• W156085488 cites W2138157385 @default.
• W156085488 cites W2147630681 @default.
• W156085488 cites W2155104279 @default.
• W156085488 cites W2155242492 @default.
• W156085488 cites W2155381255 @default.
• W156085488 cites W2156078931 @default.
• W156085488 cites W2161730699 @default.
• W156085488 cites W2163188200 @default.
• W156085488 doi "https://doi.org/10.3978/j.issn.2305-5839.2014.12.05" @default.
• W156085488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4322160" @default.
• W156085488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25738144" @default.
• W156085488 hasPublicationYear "2015" @default.
• W156085488 type Work @default.
• W156085488 sameAs 156085488 @default.
• W156085488 citedByCount "25" @default.
• W156085488 countsByYear W1560854882014 @default.
• W156085488 countsByYear W1560854882015 @default.
• W156085488 countsByYear W1560854882017 @default.
• W156085488 countsByYear W1560854882018 @default.
• W156085488 countsByYear W1560854882019 @default.
• W156085488 countsByYear W1560854882020 @default.
• W156085488 countsByYear W1560854882021 @default.
• W156085488 countsByYear W1560854882022 @default.
• W156085488 countsByYear W1560854882023 @default.
• W156085488 crossrefType "journal-article" @default.
• W156085488 hasAuthorship W156085488A5001286058 @default.
• W156085488 hasAuthorship W156085488A5028598126 @default.
• W156085488 hasAuthorship W156085488A5039457224 @default.
• W156085488 hasAuthorship W156085488A5071277883 @default.
• W156085488 hasConcept C121608353 @default.
• W156085488 hasConcept C126322002 @default.
• W156085488 hasConcept C143998085 @default.
• W156085488 hasConcept C146357865 @default.
• W156085488 hasConcept C151730666 @default.
• W156085488 hasConcept C2776131300 @default.
• W156085488 hasConcept C2777658100 @default.
• W156085488 hasConcept C2777701055 @default.
• W156085488 hasConcept C2779134260 @default.
• W156085488 hasConcept C2781230642 @default.
• W156085488 hasConcept C2908647359 @default.
• W156085488 hasConcept C2994587330 @default.
• W156085488 hasConcept C502942594 @default.
• W156085488 hasConcept C71924100 @default.
• W156085488 hasConcept C86803240 @default.
• W156085488 hasConcept C99454951 @default.
• W156085488 hasConceptScore W156085488C121608353 @default.
• W156085488 hasConceptScore W156085488C126322002 @default.
• W156085488 hasConceptScore W156085488C143998085 @default.
• W156085488 hasConceptScore W156085488C146357865 @default.
• W156085488 hasConceptScore W156085488C151730666 @default.
• W156085488 hasConceptScore W156085488C2776131300 @default.
• W156085488 hasConceptScore W156085488C2777658100 @default.
• W156085488 hasConceptScore W156085488C2777701055 @default.
• W156085488 hasConceptScore W156085488C2779134260 @default.
• W156085488 hasConceptScore W156085488C2781230642 @default.
• W156085488 hasConceptScore W156085488C2908647359 @default.
• W156085488 hasConceptScore W156085488C2994587330 @default.
• W156085488 hasConceptScore W156085488C502942594 @default.
• W156085488 hasConceptScore W156085488C71924100 @default.
• W156085488 hasConceptScore W156085488C86803240 @default.
• W156085488 hasConceptScore W156085488C99454951 @default.
• W156085488 hasIssue "2" @default.
• W156085488 hasLocation W1560854881 @default.
• W156085488 hasOpenAccess W156085488 @default.
• W156085488 hasPrimaryLocation W1560854881 @default.

• next